Walter pirker, m

Univ. Doz. Dr. Willibald Gerschlager
Krankenhaus der Barmherzigen Brüder
Neurologische Abteilung
1020 Wien
PUBLIKATIONSLISTE
ERSTAUTORSCHAFTEN
1) Gerschlager W. Kurzfassung der Dissertation: In-vivo Studie über den Einfluß von Neurotransmittern auf den Gefäßtonus. Wien Klin Wochenschr 1994;106:531-533.
(Impact Factor: 0.3).
2) Gerschlager W, Lalouschek W, Lehrner J, Baumgartner C, Lindinger G, Lang W.
Language - related hemispheric asymmetry in healthy subjects and patients with temporal lobe epilepsy as studied by event-related potentials and intracarotid amobarbital test. Electroenceph clin Neurophysiol 1998;108:274-282. (Impact Factor: 2. 5).
3) Gerschlager W, Alesch F, Cunnington R, Deecke L, Dirnberger G, Endl W, Lindinger G, Lang W. Bilateral subthalamic nucleus stimulation improves frontal cortex function in Parkinson’s disease: An electrophysiological study of the contingent negative variation.
Brain 1999;122:2365-2373. (Impact Factor: 7. 4).
4) Gerschlager W, Beisteiner R, Deecke L, Dirnberger G, Endl W, Kollegger H, Lindinger G, Vass K, Lang W. Electrophysiological, neuropsychological and clinical findings in multiple sclerosis patients receiving Interferon -1b. A 1-year follow-up. European Neurology 2000;44:205-209. (Impact Factor: 1.1).
5) Gerschlager W, Bloem BR, Alesch F, Lang W, Deecke L, Cunnington R. Bilateral subthalamic nucleus stimulation does not improve prolonged P300 latencies in Parkinson’s disease. J Neurology 2001;248:285-289. (Impact Factor 2.7).
6) Gerschlager W, Siebner HR, Rothwell JC. Decreased corticospinal excitability after subthreshold 1 Hz rTMS over lateral premotor cortex. Neurology 2001;57:449-455.
(Impact Factor: 4. 8).
7) Gerschlager W, Bencsits G, Pirker W, Bloem BR, Asenbaum S, Prayer D, Zijlmans JCM, Hoffmann M, Brücke T. [123I]-CIT SPECT distinguishes vascular parkinsonism from Parkinson’s disease. Mov Disord 2002;17:518-523. (Impact Factor: 2.5).
8) Gerschlager W, Brown P. Effect of treatment with intravenous immunoglobulin on quality of life in patients with stiff-person syndrome. Mov Disord 2002;17:590-593.
(Impact Factor: 2.5).
9) Gerschlager W, Schrag A, Brown P. Quality of life in the stiff-person syndrome. Mov Disord 2002; 17:1064-1067. (Impact Factor: 2.5).
10) Gerschlager W, Christensen LOD, Bestmann S, Rothwell JC. rTMS over the cerebellum can increase corticospinal excitability through a spinal mechanism involving activation of peripheral nerve fibres. Clin Neurophysiol 2002;113:1435-1440. (Impact Factor: 3.3).
11) Gerschlager W, Katzenschlager R, Schrag A, Lees AJ, Brown P, Quinn N, Bhatia K.
Quality of life in patients with orthostatic tremor. J Neurol 2003;2:212-215. (Impact Factor 3.3).
12) Gerschlager W, Münchau A, Katzenschlager R, Brown P, Rothwell JC, Quinn N, Lees AJ, Bhatia K. Natural history and syndromic associations of orthostatic tremor: a review of 41 patients. Mov Disord 2004;19:788-795. (Impact Factor 2.8).
13) Gerschlager W, Holler I Cunnington R, Siebner HR. 5Hz rTMS over the motor cortex improves motor symptoms in patients with Parkinson’s disease. submitted ARBEITEN ALS „SENIOR-AUTOR“
14) Bloem BR, Boers I, Cramer M, Westendorp RGJ, Gerschlager W. Falls in the elderly. I.
Identifikation of risk factors. Wien Klin Wochenschr 2001;113:352-62. (Impact Factor: 15) Holler I, Dirnberger G, Pirker W, Auff E, Gerschlager W. [123I]-CIT SPECT and clinical characteristics in two Parkinson’s disease patients associated with camptocormia. European Neurology 2003;50:118-20. (Impact Factor: 1.1).
16) Holler I, Siebner HR, Cunnington R, Gerschlager W. 5Hz repetitive TMS increases anticipatory motor activity in the human cortex. Neuroscience Letters 2006;392: 221- 225. (Impact Factor: 2.1).
KOAUTORSCHAFTEN
17) Wolzt M, Gerschlager W, Zweytick B, Sertl K, Eichler HG. Effects of NPY and VIP on human venous smooth muscle in vivo. Naunyn Schmiedebergs Arch Pharmacol 1994;350:194-200. (Impact Factor: 2.8).
18) Schnider P, Reisinger EC, Gerschlager W, Müller C, Berger T, Krejs GJ, Auff E. Long - term follow - up in cerebral Whipple’s disease. Eur J Gastroenterol Hepatol 1996;8:899- 903. (Impact Factor: 0.8).
19) Lang W, Cheyne D, Höllinger P, Gerschlager W, Lindinger G. Electric and magnetic fields of the brain accompanying internal stimulation of movements. Cognitive Brain Res 1996;3:125-29. (Impact Factor: 2.2).
20) Lalouschek W, Gerschlager W, Lehrner J, Baumgartner C, Lindinger G, Lang W. Event- related potentials in patients with temporal lobe epilepsy reveal topography specific lateralization in relation to the side of the epileptic focus. Electroenceph clin Neurophysiol 1998;108:567-76. (Impact Factor: 2.4).
21) Pirker W, Asenbaum S, Bencsits G, Prayer D, Gerschlager W, Deecke L, Brücke T.
[123I]-CIT-SPECT in multiple system atrophy, progressive supranuclear palsy and corticobasal degeneration. Mov Disord 2000;15:1158-67. (Impact Factor 2.5).
22) Touge T, Gerschlager W, Brown P, Rothwell JC. Are the after-effects of low frequency rTMS on motor cortex excitability due to changes in the efficacy of cortical synapses? Clin Neurophysiol 2001;112:2138-45. (Impact Factor: 3.3).
23) Boers I, Gerschlager W, Stalenhoef PA, Bloem BR. Falls in the elderly. II. Strategies for prevention. Wien Klin Wochenschr 2001;113:398-407. (Impact Factor: 0.6).
24) Pirker W, Djamshidian S, Asenbaum S, Gerschlager W, Tribl G, Hoffmann M, Brücke T. The progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: A longitudinal beta-CIT SPECT study. Mov Disord 2002;17:45-53.
(Impact Factor: 2.5).
25) Strens LH, Oliviero A, Bloem BR, Gerschlager W, Rothwell JC, Brown P. The effects of subthreshold 1 Hz repetitive TMS on cortico-cortical and interhemispheric coherence.
Clin Neurophysiol 2002;113:1279-85. (Impact Factor: 3.3).
26) Katzenschlager R, Costa D, Gerschlager W, O’Sullivan J, Zijlmans J, Gacinovic S, Pirker W, Wills A, Bhatia K, Lees AJ, Brown P. [123I]-FP-CIT-SPECT demonstrates dopaminergic deficit in orthostatic tremor. Ann Neurol 2003;53:489-96. (Impact Factor: 27) Siebner HR, Filipovic SR, Rowe JB, Cordivari C, Gerschlager W, Rothwell JC, Frackowiack RS, Bhatia KP. Patients with focal arm dystonia have increased sensitivity to slow-frequency repetitive TMS over the dorsal premotor cortex. Brain 2003;126:2710-25. (Impact Factor: 7.3).
28) Pirker W, Back C, Gerschlager W, Laccone F, Alesch F. Chronic thalamic stimulation in a patient with spinocerebellar ataxia type 2. Mov Disord 2003;2:221-225. (Impact Factor: 2.5).
29) Pirker W, Holler I, Gerschlager W, Asenbaum S, Zettnig G, Brucke T. Measuring the rate of progression of Parkinson’s disease over a 5-year period with beta-CIT SPECT.
Mov Disord 2003;18:1266-72. (Impact Factor: 2.5).
30) Rizzo V, Siebner HR, Modugno N, Pesenti A, Munchau A, Gerschlager W, Webb RM, Rothwell JC. Shaping the excitability of human motor cortex with premotor rTMS. J Physiol 2004;15:483-485. (Impact Factor: 4.3).
31) Filipovic SR, Siebner HR, Rowe JB, Cordivari C, Gerschlager W, Rothwell JC, Frackowiack RS, Bhatia KP. Modulation of corticalo activity by repetitive transcranial magnetic stimulation (rTMS): a review of functional imaging studies and the potential use in dystonia. Adv Neurol 2004;94:45-52. (Impact Factor: 1.4).
32) Münchau A, Langosch JM, Gerschlager W, Rothwell J, Orth M, Trimble MR.
Mirtazapine increases cortical excitability in healthy controls and epilepsy patients with major depression. J Neurol Neurosurg Psychiatry 2005;76:527-533. (Impact Factor: 2.8).
33) Sauermann S, Standhardt H, Gerschlager W, Lanmüller H, Alesch F. Kinematic evaluation in Parkinson’s disease using a hand-held position transducer and computeized signal analysis. Acta Neurochir (Wien) 2005;147:939-945. (Impact Factor: 1).
34) Rowe JB, Siebner H, Filipovic SR, Cordivari C, Gerschlager W, Rothwell JC, Frackowiak R. Aging is associated with contrasting chances in local and distant cortical connectivity in the human motor system. Neuroimage 2006;32: 747-760. (Impact Factor:

Source: http://www.parkinsonberatung.at/pdf/publikationen.pdf